{"Circulating": [0], "proteins": [1, 33, 90], "have": [2], "important": [3], "functions": [4], "in": [5, 40, 68, 78, 115, 130], "inflammation": [6], "and": [7, 57, 85, 108, 122, 141], "a": [8, 22, 143], "broad": [9], "range": [10], "of": [11, 30, 52, 88, 98, 102, 118, 138], "diseases.": [12], "To": [13], "identify": [14, 136], "genetic": [15], "influences": [16], "on": [17, 100], "inflammation-related": [18], "proteins,": [19], "we": [20, 81, 123], "conducted": [21], "genome-wide": [23, 59], "protein": [24], "quantitative": [25], "trait": [26], "locus": [27], "(pQTL)": [28], "study": [29], "91": [31], "plasma": [32], "measured": [34], "using": [35], "the": [36, 116], "Olink": [37], "Target": [38], "platform": [39], "14,824": [41], "participants.": [42], "We": [43], "identified": [44, 82], "180": [45], "pQTLs": [46], "(59": [47], "cis,": [48], "121": [49], "trans).": [50], "Integration": [51], "pQTL": [53], "data": [54], "with": [55, 132], "eQTL": [56], "disease": [58, 79], "association": [60], "studies": [61], "provided": [62], "insight": [63], "into": [64], "pathogenesis,": [65], "implicating": [66], "lymphotoxin-\u03b1": [67], "multiple": [69, 106], "sclerosis.": [70], "Using": [71], "Mendelian": [72], "randomization": [73], "(MR)": [74], "to": [75, 146], "assess": [76], "causality": [77], "etiology,": [80], "both": [83], "shared": [84], "distinct": [86], "effects": [87, 97], "specific": [89], "across": [91], "immune-mediated": [92], "diseases,": [93], "including": [94], "directionally": [95], "discordant": [96], "CD40": [99], "risk": [101], "rheumatoid": [103], "arthritis": [104], "versus": [105], "sclerosis": [107], "inflammatory": [109], "bowel": [110], "disease.": [111], "MR": [112], "implicated": [113], "CXCL5": [114, 127], "etiology": [117], "ulcerative": [119], "colitis": [120], "(UC)": [121], "show": [124], "elevated": [125], "gut": [126], "transcript": [128], "expression": [129], "patients": [131], "UC.": [133], "These": [134], "results": [135], "targets": [137], "existing": [139], "drugs": [140], "provide": [142], "powerful": [144], "resource": [145], "facilitate": [147], "future": [148], "drug": [149], "target": [150], "prioritization.": [151]}